Accounts Payable - AVROBIO Inc (NASDAQ:TECX) - Alpha Spread

AVROBIO Inc
NASDAQ:TECX

Watchlist Manager
AVROBIO Inc Logo
AVROBIO Inc
NASDAQ:TECX
Watchlist
Price: 19.14 USD 0.74%
Market Cap: 281.9m USD
Have any thoughts about
AVROBIO Inc?
Write Note

AVROBIO Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AVROBIO Inc
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
AVROBIO Inc
NASDAQ:TECX
Accounts Payable
$27k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Payable
$29.3B
CAGR 3-Years
12%
CAGR 5-Years
21%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
$537m
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$2.3B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$327.9m
CAGR 3-Years
37%
CAGR 5-Years
34%
CAGR 10-Years
20%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$561.7m
CAGR 3-Years
6%
CAGR 5-Years
18%
CAGR 10-Years
28%

See Also

What is AVROBIO Inc's Accounts Payable?
Accounts Payable
27k USD

Based on the financial report for Dec 31, 2023, AVROBIO Inc's Accounts Payable amounts to 27k USD.

What is AVROBIO Inc's Accounts Payable growth rate?
Accounts Payable CAGR 1Y
-93%

Over the last year, the Accounts Payable growth was -93%.

Back to Top